Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B

Clinical trial NCT01595685 · COMPLETED

Trial details

NCT number: NCT01595685
Sponsor: Asan Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Viral Hepatitis B Without Delta-agent

Start date: 2012-05-01
Primary completion: 2014-12-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.